Trial intelligence / Profile preview

PK of Colcrys in Renal Impairment

NCT01084278Phase 4Completed

Sponsor
Takeda
Start
May 2010
Primary completion
Feb 2011
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of colchicine in gout, sponsored by Takeda. Started May 2010; status: completed.

02

Drugs

colchicine
03

Conditions

gout

Beyond the preview

Go deeper on NCT01084278.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01084278.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call